Showing 1 - 20 results of 359 for search '"galantamine"', query time: 0.16s Refine Results
  1. 1

    Galantamine in Alzheimer's disease. by Razay, G, Wilcock, G

    Published 2008
    “…Galantamine is a cholinesterase inhibitor with a dual mechanism of action. …”
    Journal article
  2. 2
  3. 3

    Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine by Yukio Ago, Ken Koda, Kazuhiro Takuma, Toshio Matsuda

    Published 2011-01-01
    “…Keywords:: galantamine, psychiatric disorder, acetylcholinesterase, nicotinic and muscarinic receptors, neurotransmitter release…”
    Get full text
    Article
  4. 4
  5. 5

    QT interval prolongation and with donepezil, rivastigmine and galantamine by Katie Malone, Jules C. Hancox

    Published 2020-08-01
    “…Background: Acetylcholinesterase inhibitors (AChEis) including donepezil, galantamine and rivastigmine are used to treat Alzheimer’s disease (AD). …”
    Get full text
    Article
  6. 6
  7. 7

    Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group. by Wilcock, G, Lilienfeld, S, Gaens, E

    Published 2000
    “… OBJECTIVE: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. …”
    Journal article
  8. 8
  9. 9
  10. 10

    The effects of galantamine treatment on caregiver time in Alzheimer's disease. by Sano, M, Wilcock, G, van Baelen, B, Kavanagh, S

    Published 2003
    “… AIM: The aim of the study was to determine whether the clinical benefits of galantamine for patients with Alzheimer's disease lead to benefits for caregivers. …”
    Journal article
  11. 11

    Safety and efficacy of galantamine in subjects with mild cognitive impairment. by Winblad, B, Gauthier, S, Scinto, L, Feldman, H, Wilcock, G, Truyen, L, Mayorga, A, Wang, D, Brashear, H, Nye, J

    Published 2008
    “… OBJECTIVE: To assess the safety of galantamine in subjects with mild cognitive impairment (MCI), the ability of galantamine to benefit cognition and global functioning in subjects with MCI, and the ability of galantamine to delay conversion to dementia. …”
    Journal article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Preparation and evaluation of novel galantamine hydrobromide sustained-release capsule by Shuoye Yang

    Published 2016-03-01
    Subjects: “…Galantamine hydrobromide…”
    Get full text
    Article
  17. 17

    Changes in electrophysiological markers of cognitive control after administration of galantamine by Lauren E. Gascoyne, Karen J. Mullinger, Siân E. Robson, Jyothika Kumar, George C. O'Neill, Lena Palaniyappan, Peter G. Morris, Elizabeth B. Liddle, Matthew J. Brookes, Peter F. Liddle

    Published 2018-01-01
    “…In the galantamine condition, we found a significant reduction in the post-movement beta rebound in the case of executed movements and also in a planned but not executed movement. …”
    Get full text
    Article
  18. 18

    Ameliorative effect of galantamine on acetic acid-induced colitis in rats by Niloofar-Sadat Mahdavi, Ardeshir Talebi, Mohsen Minaiyan

    Published 2019-01-01
    Subjects: “…anticholinergic; anti-inflammatory; dicyclomine; galantamine; ulcerative colitis; rats…”
    Get full text
    Article
  19. 19
  20. 20

    Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine by Maju Mathew Koola

    Published 2016-06-01
    “…There is evidence to suggest that the combination of galantamine and memantine may be effective in the treatment of cognitive impairments in schizophrenia. …”
    Get full text
    Article